 |
|
|
| |
Evaluation of Drug Interactions between
Dolutegravir and Daclatasvir in Healthy Subjects
|
| |
| |
Reported by Jules Levin
16th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2015, Washington, DC
1Song1, F. Jerva2, J. Zong1, M. Choukour3, B. Wynne4, A. Buchanan4, T. Eley5, S.P. Huang6, L. Ross71GSK, CPMS, Research Triangle Park, USA; 2GSK, CPSSO, Research Triangle Park, USA; 3Parexel, Clinical Statistics, Tampa, USA; 4GSK, MD ID, Research Triangle Park, USA; 5BMS, Clinical Pharmacology, Princeton, USA; 6BMS, Clinical Statistics, Princeton, USA; 7ViiV Healthcare, Clinical Science, Research Triangle Park, USA
|
| |
|
|
|
|
|
